Noxalk Ceritinib 150 Mg Capsules

Description

Introduction Of Noxalk 150 Mg Capsule:

Noxalk is a cancer medicine used on its own to treat adults with a type of lung cancer called non-small-cell lung cancer (NSCLC), when the disease is advanced. It is only used if the NSCLC is ‘ALK-positive’, which means that the cancer cells have certain defects affecting the gene responsible for a protein called ALK (anaplastic lymphoma kinase).

Noxalk contains the active substance ceritinib.

Uses Of Noxalk 150 Mg Capsule:

It is used for lung cancer that have a certain type of abnormal ‘’ ALK ‘’ gene

Mechanism Of Action Of Noxalk 150 Mg:

ALK belongs to a family of proteins called receptor tyrosine kinases, which are involved in the growth of cells and the development of new blood vessels that supply them. In patients with ALK-positive NSCLC, an abnormal form of ALK is produced that stimulates the cancer cells to divide and grow in an uncontrolled fashion. The active substance in Noxalk, ceritinib, works by blocking the activity of ALK, thereby reducing the growth and spread of the cancer.